Cozzi NV

Alexander Shulgin Research Institute, 1483 Shulgin Road, Lafayette, CA, 94549, USA. cozzi@wisc.edu.

1 preprint · 7 papers · ORCID

PreprintDMT

Direct anti-inflammatory actions of <i>N,N</i> -dimethyltryptamine on microglia are revealed by proteomic profiling and receptor pharmacology

Pesti I, Bessenyei Á, Frank R +12

Europe PMC2026
ArticlePsychedelics

Serotonin 2A receptor binding, functional activity, and in vitro metabolism of two trideuteromethoxy 2C-B isotopologues.

Cozzi NV

Europe PMC2026
ArticleDMT

Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder.

D'Souza DC, Syed SA, Flynn LT +3

Europe PMC2022
ArticlePsilocybin

Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.

Schindler EAD, Sewell RA, Gottschalk CH +6

Europe PMC2021
ArticlePsilocybin

Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials.

Cozzi NV, Daley PF

Europe PMC2020
ArticlePsilocybin

Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of Psilocybin.

Kargbo RB, Sherwood A, Walker A +8

Europe PMC2020
ArticlePsilocybin

High dose psilocybin is associated with positive subjective effects in healthy volunteers.

Nicholas CR, Henriquez KM, Gassman MC +7

Europe PMC2018
ArticlePsychedelics

Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs.

Klein LM, Cozzi NV, Daley PF +2

Europe PMC2018